Impact of the Daily Consumption of L.Reuteri-containing Lozenges on Oral and General Health in Crew Members of a Naval Ship at Sea
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Acute enterocolitis; Gastrointestinal disorders; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Dec 2020 New trial record